Early Success in Trials to Treat Endometriosis Symptoms

Gynica’s preclinical trial of a cannabinoid-based treatment for endometriosis is already showing promising results. The study is led by Prof. Lumir Ondrej Hanus, the chemist responsible for the definition and isolation of active cannabinoid compounds in 1992.

HIGHLIGHTS

• Gynica, Lumir Lab, and Canadian startup Strainprint have announced a partnership to develop the world’s first and largest database of the effects of cannabis on women, starting with a focus on endometriosis symptoms.
• A clinical trial led by Gynica’s Principle Investigator and global leading endometriosis specialist Dr. Yuval Kaufman, is slated for Q1 2020.
• The trial involves jointly recruiting patients in Israel and Canada to gather, store, and monitor patient data.

Read more at Gynica.com